Projected to grow from US$22.58 billion in 2024 to US$171.79 billion by 2033 at 25.5% CAGR, the biosimilars market thrives on therapeutic expansions. Dive into segmentation by product type, key approvals like Omlyclo, and challenges in manufacturing amid patient access demands. https://finance.yahoo.com/news/biosimilars-market-surpass-us-171-141500245.html